Gut dysbiosis in primary sarcopenia: potential mechanisms and implications for novel microbiome-based therapeutic strategies
Primary sarcopenia is characterized by a progressive loss of skeletal muscle mass, strength, and physical function that occurs with aging. Despite the related adverse or even serious health outcomes, no medications are currently available for treating primary sarcopenia. Here, we discuss recent adva...
Saved in:
Main Authors: | Wei Yang, Si-Cong Si, Wei-Hua Wang, Jing Li, Yi-Xin Ma, Huan Zhao, Jia Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2025.1526764/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gut microbiota in patients with sarcopenia: a systematic review and meta-analysis
by: Guangning Wang, et al.
Published: (2025-01-01) -
Research progress of gut microbiome and diabetic nephropathy
by: Chenling Chu, et al.
Published: (2024-12-01) -
Corrigendum: Research progress of gut microbiome and diabetic nephropathy
by: Chenling Chu, et al.
Published: (2025-01-01) -
The gut microbiome and cross-reactivity of food allergens: current understanding, insights, and future directions
by: Carolina Taico Oliva, et al.
Published: (2025-01-01) -
The gut microbiome, immune modulation, and cognitive decline: insights on the gut-brain axis
by: Ruyi Zhang, et al.
Published: (2025-01-01)